PBM Audit Reform and Transparency Act of 2010

H.R. 5234, PBM Audit Reform and Transparency Act of 2010, to ensure transparency and proper operation of pharmacy benefit managers Discussions regarding generic drugs (no bill)

Client expense: $1,540,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Federal Highway Administration (FHA), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

Legislation concerning privacy regarding inadvertent disclosure of protected health information; HR 5777 (Rush Privacy bill); S. 3742 - Data Security and Breach Notification Act of 2010. Legislation concerning pharmacy benefit management issues, drug safety and tracking drug suppliers; S.3397, HR 1359, HR 5710. (et al., HR 4199, HR 5234, HR 4489, HR 4213).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Healthcare reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections H.R. 4199 - Patient Health and Reinvestment Act of 2009; all sections H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Rate Commission, Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS)

Issues related to anti-PBM legislation, disclosure of proprietary pricing and contracting information. Other issues included health care delivery system reforms, cost containment, restrictions on PBM cost saving tools like mail order, and generics, restrictions on PBM audit practices and new rules around IRS Form 1099. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009 HR 5234 PBM Audit Reform and Transparency Act of 2010 HR 4489 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act

Client expense: $2,189,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act

Client expense: $36,675 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act

Client expense: $36,675 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act

Client expense: $36,675 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.5234, the PBM Audit Reform and Transparency Act of 2010 H.R. 4994, Medicare and Medicaid Extenders Act of 2010 H.R. 4853, Tax Relief, Unemployment Insurance Reauthorization and Job Creation Act of 2010

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Items related to reverse settlement payments between manufacturers--HR 1706, S 369; Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489; Regulatory design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements; Policies related to restricting PBMS' ability to manage prescription drug benefits-- HR 4199; PBM Audit Reform & Transparency Act--HR 5234.

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 4489, the FEHBP Prescription Integrity, Transparency and Cost Savings Act of 2010; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and Pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 4853, the Tax Re Relief and Job Creation Act of 2010-worked to get provisions related to Part B DME competitive bidding program included in the legislation; H.R. 6523, the National Defense Authoirzation Act for 2011, includes funding for the Department of Defense and covers the TRICARE pharmacy program; worked with Senate offices to gain support for the implementation of an authorized grant program for MTM services; worked with Senate Aging Committee on the issues of nurses-as-agents in long term care facilities and submitted questions for the nomination hearing of Drug Enforcement Agency Acting Administrator Michele Leonhart; worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sought Congressional support for the FTC investigation of the merger of between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices seeking clarification from the Department of Treasury regarding the new "over the counter" rules with Flexible Spending Accounts (FSA).

Client expense: $130,000 · Firm income: Not reported

H.R. 5234, PBM Audit Reform and Transparency Act of 2010, to ensure transparency and proper operation of pharmacy benefit managers Discussions regarding generic drugs (no bill)

Client expense: $1,390,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Federal Highway Administration (FHA), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $525,828 · Firm income: Not reported

Legislation concerning privacy regarding inadvertent disclosure of protected health information; HR 5777 (Rush Privacy bill); S. 3742-Data Security and Breach Notification Act of 2010. Legislation concerning pharmacy benefit management issues, drug safety and tracking drug suppliers; S.3397, HR 1359, HR 5710. (et al., HR 4199, HR 5234, HR 4489, HR 4213).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

healthcare reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program Public Law 111-148 - Patient Protection and Affordable Care Act (formerly H.R. 3590); all sections H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections H.R. 4199 - Patient Health and Reinvestment Act of 2009 H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections

Client expense: $960,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Regulatory Commission, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.4213, The American Jobs and Closing Tax Loopholes Act of 2010 H.R.5234, the PBM Audit Reform and Transparency Act of 2010

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of network pharmacies. Issues relating to the inadvertent disclosure of protected health information. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009 HR 5234 PBM Audit Reform and Transparency Act of 2010 HR 4489 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act HR 5777 - To foster transparency about the commercial use of personal information, provide consumers with meaningful choice about the collection, use, and disclosure of such information, and for other purposes. (Rush Privacy bill) S 3742 - Data Security and Breach Notification Act of 2010

Client expense: $2,550,000 · Firm income: Not reported

H.R. 5234, PBM Audit Reform and Transparency Act of 2010, to ensure transparency and proper operation of pharmacy benefit managers Discussions regarding generic drugs (no bill)

Client expense: $1,190,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Federal Highway Administration (FHA), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act

Client expense: $430,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 1204, the Community Pharmacy Fairness Act of 2009; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; worked with the Senate Committee on Aging to provide information for an ongoing committee investigation of certain retail pharmacy practices; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; submitted statement for the House Committee on Energy and Commerce hearing on the Part B DME competitive bidding program; H.R. 1586, the Education Jobs and Medicaid funding bill, which included an extension of FMAP and change to the AMP definition and became law on 8/10/2010; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act, includes funding for the Department of Defense and covers the TRICARE pharmacy program; H.R. 3108 and S. 1383, the Medication Therapy Management (MTM) Expanded Benefit Act; worked with Senate offices to gain support for the implemenation of an authpirzed grant program for MTM services; worked with Senate Aging Committee on the issue of nurses as agents in long-term care facilties; H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 (NASPER); H.R. 5809, the Safe Drug Disposal Act and S. 3397, the Secure & Responsible Drug Disposal Act (became law 10-12-10); worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sough Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices in seeking clarification from the Department of Treasury regarding the new "over the counter" rules with Flexible Spending Accounts (FSA).

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $644,766 · Firm income: Not reported

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of suspect network pharmacies. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009; HR 5234 PBM Audit Reform and Transparency Act of 2010. Issues relating to a proposed anti-trust exemption for certain pharmacies, healthcare competition and the CVS Caremark business model. HR 1204 - Community Pharmacy Fairness Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

health care reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program Public Law 111-148 - Patient Protection and Affordale Care Act; all sections (formerly H.R. 3590) H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections

Client expense: $600,000 · Firm income: Not reported

H.R. 1204, the Community Pharmacy Fairness Act of 2009 and S. 2191, the Community Pharmacy Fairness Act from the 110th Congress; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; H.R. 6331 (110th Congress), the Medicare Improvement for Patients and Providers Act of 2008-Sec. 172 related to the implementation of the Medciare Part D prompt pay requirements and submission of claims by pharmacies located in or contracting with long-term care facilities; H.R. 5235, the Medicare Access to Diabetic Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010-advocated for inclusion of the extension of the Federal Medicaid Matching Rate (FMAP) and limiting access to 340b drugs in outpatient settings to only eligible individuals in both House bill and Senate amendment; H.R. 5839 (110th Congress) the Safeguarding America's Pharmaceuticals Act of 2008, provisions related to pedigree and track and trace requirements-no bill introduced in the current Congress; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act , includes funding for the Department of Defense FY11 budget and covers the TRICARE pharmacy program; H.R. 3108 and S. 3543, the Medication Therapy Management Expanded Benefit Act; H.R. 2923, the Combat Meth Act of 2009; S. 1383, the Dextromethorphan Abuse Reduction Act of 2009; submitted comments to Senate Committee on Aging on prescription drug disposal and the role of nurses as agents in long-term care facilities; sought Congressional support to stop exclusion of certain retail pharmacies from "employee prescription drug plans;" worked with Congressional offices to request the FTC review the 180 day generic drug marketing exclusivity policies of certain generic manufacturers; sought Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); submitted comments to Senate Judiciary Committee regarding the FTC and DOJ antitrust oversight; submitted comments to Senate Homeland Security and Government Affairs Committee regarding a HHS OIG report, "Invalid Prescriber Identifiers on Medicare Part D Drug Claims;" FSA debit card program-seeking Congressional support to amend IRS guidance (no legislation).

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.4213, The American Jobs and Closing Tax Loopholes Act of 2010 H.R.4199, the Patient Health and Real Medication Access Cost Savings Act of 2009 H.R.5234, the PBM Audit Reform and Transparency Act of 2010

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

H.R. 5234, PBM Audit Reform and Transparency Act of 2010, to ensure transparency and proper operation of pharmacy benefit managers

Client expense: $1,430,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Highway Administration (FHA), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act

Client expense: $410,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of suspect network pharmacies. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009 HR 5234 PBM Audit Reform and Transparency Act of 2010

Client expense: $2,250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590 Patient Protection and Affordable Care Act specifically Average Manufacturer Price Pharmacy Reimbursement H.R. 3590 DMEPOS Pharmacy Accreditation H.R. 3590 PBM Transparency in Health Insurance "Exchanges" H.R. 3590 H.R. 5235, Medicare Access to Diabetes Supplies Act. H.R. 3790 Repeal DMEPOS Competitive Bidding H.R. 5234 The PBM Audit and Transparency Act of 2010

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported